freemancintron

إنشاء مقالة جديدة

1 د

Why Some People Nearly At all times Make/Save Cash With Oncology | #oncology

Why Some People Nearly At all times Make/Save Cash With Oncology

Why Some People Nearly At all times Make/Save Cash With Oncology

Oncology Frontier: In keeping with the first outcomes from MARIPOSA (LBA14), please discuss the worth of amivantamab plus lazertinib in first-line therapy in patients with EGFR-mutated Superior NSCLC.

إعجاب

علق

شارك

تحميل المزيد من المنشورات

معلومات

1 المشاركات
أنثى

الألبومات

(0)

متابَعون

(0)

متابِعون

(0)

الإعجابات

(0)

المجموعات

(0)